Our findings suggest that cytoplasmic precursor CLU is capable of potently suppressing lung cancer progression by inhibiting the ROCK1/ERK axis, which might provide a potential anti-metastasis strategy for the treatment of metastatic lung cancer. This evidence concerns the gene MAPK1 and lung carcinoma.